KRT7 and prostate adenocarcinoma: Nader H. Bassily et al.‎ in a study on the incidence of two markers, CK7 and CK20, in prostate adenocarcinoma and bladder transitional cell carcinoma, found that the combination of these two markers is useful for differentiating these tumors (28).